...
机译:pH-响应纳米颗粒靶向内体中的神经激素1受体,以防止慢性疼痛
Monash Univ Monash Inst Pharmaceut Sci Parkville Vic Australia;
Monash Univ Monash Inst Pharmaceut Sci Parkville Vic Australia;
Monash Univ Monash Inst Pharmaceut Sci Parkville Vic Australia;
Monash Univ Monash Biomed Discovery Inst Melbourne Vic Australia;
Monash Univ Monash Biomed Discovery Inst Melbourne Vic Australia;
Monash Univ Monash Inst Pharmaceut Sci Parkville Vic Australia;
Univ Santiago De Chile Ctr Dev Nanosci &
Nanotechnol CEDENNA Lab Neurobiol Santiago Chile;
Univ Santiago De Chile Ctr Dev Nanosci &
Nanotechnol CEDENNA Lab Neurobiol Santiago Chile;
Monash Univ Monash Inst Pharmaceut Sci Parkville Vic Australia;
Monash Univ Monash Inst Pharmaceut Sci Parkville Vic Australia;
Monash Univ Monash Inst Pharmaceut Sci Parkville Vic Australia;
Monash Univ Monash Inst Pharmaceut Sci Parkville Vic Australia;
Monash Univ Monash Inst Pharmaceut Sci Parkville Vic Australia;
Monash Univ Monash Inst Pharmaceut Sci Parkville Vic Australia;
Monash Univ Monash Inst Pharmaceut Sci Parkville Vic Australia;
Monash Univ Monash Inst Pharmaceut Sci Parkville Vic Australia;
Columbia Univ Dept Surg Vagelos Coll Phys &
Surg New York NY 10027 USA;
Columbia Univ Dept Surg Vagelos Coll Phys &
Surg New York NY 10027 USA;
NYU Coll Dent Bluestone Ctr Clin Res New York NY USA;
NYU Coll Dent Bluestone Ctr Clin Res New York NY USA;
Monash Univ Monash Inst Pharmaceut Sci Parkville Vic Australia;
Monash Univ Monash Inst Pharmaceut Sci Parkville Vic Australia;
Monash Univ Monash Inst Pharmaceut Sci Parkville Vic Australia;
Monash Univ Monash Inst Pharmaceut Sci Parkville Vic Australia;
Monash Univ Monash Inst Pharmaceut Sci Parkville Vic Australia;
机译:pH-响应纳米颗粒靶向内体中的神经激素1受体,以防止慢性疼痛
机译:神经激肽NK1和NK3受体可作为治疗胃肠动力障碍和疼痛的药物的靶标。
机译:Neurokinin-1和细胞因子受体作为治疗慢性普里吉的靶标
机译:用口服阿片类药物治疗慢性疼痛患者全长神经蛋白-1受体的全血mRNA
机译:在人类结肠炎相关癌症中,从慢性炎症过渡到癌变过程中的结肠上皮基因:关注截短的神经激肽1受体。
机译:内体中的神经激肽1受体信号传导介导持续的伤害感受是延长疼痛缓解的可行治疗靶标
机译:一种脂质锚定的神经蛋白1受体拮抗剂通过靶向血浆膜和底皮体的受体的三管齐下的作用机制延长了疼痛缓解